-
Balanced Chromosomal Rearrangements and Carrier Status Detection: The Slippery Slope of the Quest for Perfection. Fertil. Steril. (IF 6.6) Pub Date : 2025-05-26
Irene Souter -
Corrigendum to "Minimum number of mature oocytes needed to obtain at least one euploid blastocyst according to female age in in vitro fertilization treatment cycles" (Fertil Steril 2024;122:658-66). Fertil. Steril. (IF 6.6) Pub Date : 2025-05-24
Cristina Rodríguez-Varela,Juan Manuel Mascarós,Elena Labarta,Noelia Silla,Ernesto Bosch -
Refining GLP-1RA Therapy in PCOS: Addressing Phenotypic, Racial, and Pharmacologic Heterogeneity. Fertil. Steril. (IF 6.6) Pub Date : 2025-05-23
Shengyue Jin -
-
Assessment of Five Miscarriages with Transcervical Embryoscopy. Fertil. Steril. (IF 6.6) Pub Date : 2025-05-21
Pinar Calis,Gurkan Bozdag,Mehmet Erdem,Ahmet Erdem,Deniz Karcaaltincaba -
Live Birth Rate Outcomes Following a Change in Endometrial Preparation After a Failed Frozen Embryo Transfer Cycle. Fertil. Steril. (IF 6.6) Pub Date : 2025-05-21
Maren Bettermann,Rachel Mejia,Karen Summers,Amy Sparks -
Effect of Denosumab on Semen Quality in Infertile Men Selected by Serum Level of Anti-Müllerian Hormone: A Randomized Controlled Trial. Fertil. Steril. (IF 6.6) Pub Date : 2025-05-20
Sam Kafai Yahyavi,Rune Holt,Mads Joon Jorsal,Gustav Wall-Gremstrup,Frederikke Bay Toft,Li Juel Mortensen,Bugge Nøhr,Linda Magnusson Melsen,Lisbeth Prætorius,Henriette Svarre Nielsen,Anja Pinborg,Jens-Erik Beck Jensen,Peter Schwarz,Finn Noe Bennedbæk,Lise Aksglaede,Anne Jørgensen,Niels Jørgensen,Jørgen Holm Petersen,Anders Juul,Martin Blomberg JensenOBJECTIVE Mouse models, human testicular tissue models, and clinical intervention studies have suggested that the RANKL-inhibitor denosumab, normally used to treat osteoporosis, can improve semen quality in a sub-population of infertile men. This trial aimed to determine whether denosumab could improve sperm concentration in infertile men selected by serum AMH ≥ 38 pmol/L. DESIGN A double-blinded,
-
Advanced maternal age was associated with an annual decline in reproductive success despite use of donor oocytes: A retrospective study. Fertil. Steril. (IF 6.6) Pub Date : 2025-05-20
Patricia Sebastian-Leon,Francisco Jose Sanz,Pietro Molinaro,Antonio Pellicer,Patricia Diaz-GimenoOBJECTIVE To study if there is an increasing risk of poor reproductive outcomes associated with age in IVF patients using donor oocytes and when it becomes clinically relevant. DESIGN Multicenter, retrospective cohort study SUBJECTS: IVF patients ≥35 years at 19 private fertility clinics in Spain. EXPOSURE A single day 5 embryo from a donor oocyte (<35 years) transferred to the IVF patient undergoing
-
Where will science take assisted reproduction? Fertil. Steril. (IF 6.6) Pub Date : 2025-05-20
Marcelle I. Cedars M.D.This month’s Views and Reviews opens a window to the future. What lies on the horizon for assisted reproduction and gamete/embryo biology? We focus on in vitro gametogenesis and germline editing. Czukiewska et al. reviewed the current state of the science of female germ cell development. This well-supported section recognizes the progress made and the unique aspect of oogenesis that makes full maturation
-
Progestin prime ovarian stimulation provides comparable outcomes to GnRH antagonist in donor cycles with vitrified oocytes. Fertil. Steril. (IF 6.6) Pub Date : 2025-05-20
Lucía Murria,Juan Giles,Lorena Bori,José Remohí,Ana CoboOBJECTIVE To compare the effectiveness and safety of Medroxyprogesterone Acetate (MPA) and Gonadotropin-Releasing Hormone antagonist (GnRHant) protocols in vitrified donor oocyte cycles and expand the current evidence on their clinical outcomes DESIGN: Retrospective cohort study SUBJECTS: This study included 14,981 recipients who received vitrified oocytes coming from 3,599 donors stimulated with MPA
-
Orally active GnRH antagonists: Are we witnessing a revolution in oral contraception? Fertil. Steril. (IF 6.6) Pub Date : 2025-05-20
Richard J Paulson -
Male Fertility Restoration with Stem Cell-Based Therapies: From Testicular Stem Cells to Pluripotent Stem Cell-based In Vitro Gametogenesis. Fertil. Steril. (IF 6.6) Pub Date : 2025-05-19
Young Sun Hwang,Amander T ClarkMale infertility poses a substantial clinical challenge, affecting 8-12% of couples worldwide. The underlying causes of this condition range from cancer treatments to congenital disorders. The present approach to fertility preservation entails the cryopreservation of sperm for post-pubertal males. However, this method offers limited options for prepubertal patients and those with non-obstructive azoospermia
-
Prospective validation of anti-Müllerian hormone cut-off to determine polycystic ovarian morphology: HARMONIA study. Fertil. Steril. (IF 6.6) Pub Date : 2025-05-19
Terhi T Piltonen,Jenni Kinnunen,Elina Komsi,Marika H Kangasniemi,Kaisu Luiro,Maria Rajecki,Jari Jokelainen,Eetu Kiviniemi,Deirdre Allegranza,Martin Hund,Anna-Maria Olziersky,Chad A Logan,Katharina Buck,Susanna M Savukoski,Riikka K ArffmanOBJECTIVE To verify the anti-Müllerian hormone cut-off (3.2 ng/mL) for the determination of polycystic ovarian morphology as part of the latest polycystic ovary syndrome diagnosis in an independent prospective cohort of women of reproductive age. DESIGN A prospective, population-based, non-interventional study. SUBJECTS Women enrolled in the Northern Finland Birth Cohort 1986, and women born in the
-
Effect of vanishing twin on singleton neonatal outcomes in frozen embryo transfer cycles: a cohort study. Fertil. Steril. (IF 6.6) Pub Date : 2025-05-19
Tingting He,Wenhao Shi,Xia Xue,Juanzi ShiOBJECTIVE To investigate the association between vanishing twin syndrome (VTS) and adverse neonatal outcomes in singleton live births resulting from frozen embryo transfer (FET) cycles. DESIGN Retrospective cohort study. SUBJECTS This retrospective study involved a total of 14,583 women who underwent FET cycles and resulted in a live singleton newborn from January 2015 to June 2022. EXPOSURE Women
-
Cost considerations for uterine transplant Fertil. Steril. (IF 6.6) Pub Date : 2025-05-16
Amanda A. Honeycutt Ph.D. -
The Missing Pieces in Clomiphene Citrate Safety Data: Long-Term Outcomes and Genetic Considerations. Fertil. Steril. (IF 6.6) Pub Date : 2025-05-14
Zongyu Yang,Songjie Liao,Liqiu Kou -
IMPACT OF BILATERAL INTRAOVARIAN PLATELET-RICH PLASMA IN WOMEN WITH POOR OVARIAN RESPONSE OR PRIMARY OVARIAN INSUFFICIENCY. A RETROSPECTIVE STUDY. Fertil. Steril. (IF 6.6) Pub Date : 2025-05-14
Pietro Molinaro,Ana Ballester,Juan A Garcia-Velasco,Manuel Muñoz,Sonia HerraizOBJECTIVE To investigate the association of autologous platelet-rich plasma (PRP) treatment with functional ovarian reserve parameters and in vitro fertilization outcomes of poor ovarian responders and women with primary ovarian insufficiency (POI) who refused oocyte donation. DESIGN Observational, retrospective, multicentric cohort study SUBJECTS: Three hundred and fifty-three women who underwent
-
Special Considerations in Assisted Reproductive Technology for Patients with Obesity. Fertil. Steril. (IF 6.6) Pub Date : 2025-05-09
Austin P Johnson,Thanh-Giang T Vu,Judy Simon,Ginny L RyanObesity rates are rising and patients with obesity may disproportionately seek fertility preservation and fertility treatment due to higher risk of related disease. At the same time, IVF centers across the United States are increasingly setting BMI cut-offs above which treatment will not be provided. Patients experience these limits as another example of stigma in healthcare as well as an access challenge
-
Use of oral contraceptive pills before natural frozen embryo transfer cycles: impact on pregnancy and live birth Fertil. Steril. (IF 6.6) Pub Date : 2025-05-08
Meridith Paige Pollie M.D., Leigh Ann Humphries M.D. M.S.C.E., Daniel Miranian M.D., Cassie Tian B.S., Divya Kelath Shah M.D. M.M.E. -
Recurrent pregnancy loss as an independent risk factor for celiac disease of the offspring. Fertil. Steril. (IF 6.6) Pub Date : 2025-05-08
Shay Benshalom,Gil Gutvirtz,Gali Pariente,Tamar Wainstock,Eyal Sheiner -
Comparing Blastulation of Surgically Retrieved Sperm to Ejaculated Sperm in Donor Oocyte Cycles. Fertil. Steril. (IF 6.6) Pub Date : 2025-05-08
Amalia Namath,Kerry Flannagan,Kyle Le,Atoosa Ghofranian,Jensen Reckhow,Allison Eubanks,Anupama Rambhatla,Michael Homer,Meike L Uhler,Luis R Hoyos,Jessica Marinaro,Phillip Romanski,Lauren RothOBJECTIVE To evaluate availability of usable blastocysts and blastulation from donor oocytes fertilized with surgically retrieved sperm among patients with obstructive azoospermia (OA) and non-obstructive azoospermia (NOA) compared with ejaculated sperm DESIGN: Retrospective cohort study SETTING: A multi-center assisted reproductive technology practice SUBJECTS: Patients that used fresh or frozen donor
-
Epidemiology of falling fertility: the contribution of social, environmental, and genetic forces Fertil. Steril. (IF 6.6) Pub Date : 2025-05-08
Robert John Aitken Ph.D., Robert John Norman M.D.The past half century has witnessed a dramatic decline in human fertility as reflected in the total fertility rate. This decline in total fertility rate is thought to have been triggered by an increase in resources and knowledge that precipitated a significant decline in infant mortality. This, in turn, led to a reduction in the desire of couples to have large families, supported in recent times by
-
Preimplantation genetic testing for aneuploidy—the three wise monkeys Fertil. Steril. (IF 6.6) Pub Date : 2025-05-08
Raoul Orvieto M.D. M.M.Sc. -
The chorionic bump is a predictor of miscarriage: a retrospective analysis of 13,656 in vitro fertilization pregnancies Fertil. Steril. (IF 6.6) Pub Date : 2025-05-08
Jennifer T. Zhang M.D., Blake Vessa M.D., Pavan Gill M.D., Alejandro Sánchez-Martínez M.S., Christine Whitehead M.S., Marie Werner M.D. H.C.L.D., Paul Bergh M.D.To determine the prevalence of an ultrasound-defined chorionic bump (CB) in an in vitro fertilization (IVF) population and its association with clinical loss, preterm delivery, and additional pregnancy complications.
-
Sperm cryopreservation best practices prior to gonadotoxic treatment: Recommendations from leaders in fertility preservation. Fertil. Steril. (IF 6.6) Pub Date : 2025-05-07
Jerrine R Morris,Andre Belarmino,Joyce Reinecke,Lynn Davis,Gwendolyn P Quinn,Rebecca Flyckt,Joshua Halpern,Brad Milette,James F Smith -
Eight steps to success: minimally invasive surgical management of cesarean scar pregnancy Fertil. Steril. (IF 6.6) Pub Date : 2025-05-07
Lauren van Reesema M.D., Caroline Shadowen M.D., Jeffrey J. Woo M.D.To provide an overview of cesarean scar pregnancy (CSP) including its risk factors and diagnosis, describe a case of CSP managed via robot-assisted laparoscopic resection, and provide eight tips for minimally invasive surgical management of such cases. Currently, there is no gold standard treatment for CSP. Therefore, treatment options include a wide array of surgical and nonsurgical therapies. The
-
-
Special considerations in assisted reproductive technology for patients with medically complex disease Fertil. Steril. (IF 6.6) Pub Date : 2025-05-05
Christina E. Boots M.D., Eve C. Feinberg M.D.This Views and Reviews is a series of articles on special considerations for assisted reproductive technology in patients with medically complex disease. Each piece combines a review of the literature with expert opinion on the provision of safe fertility care in the settings of cardiac disease, pulmonary disease, obesity, and hematologic disease. These articles highlight the importance of a multidisciplinary
-
The case for germline gene correction: state of the science Fertil. Steril. (IF 6.6) Pub Date : 2025-05-05
Paula Amato M.D., Aleksei Mikhalchenko Ph.D., Shoukhrat Mitalipov Ph.D.Germline gene editing refers to altering the DNA in the reproductive cells (gametes or embryos). Germline gene editing experiments in human embryos have primarily focused on correcting genetic mutations linked to inherited diseases. This technology has the potential to prevent genetic disease before birth and in future generations. Advances in CRISPR-Cas9 and other gene-editing tools have accelerated
-
Human and non-human primate female in vitro gametogenesis toward meiotic entry: a systematic review Fertil. Steril. (IF 6.6) Pub Date : 2025-05-05
Sylwia M. Czukiewska Ph.D., Celine M. Roelse M.Sc., Susana M. Chuva de Sousa Lopes Ph.D.In vitro gametogenesis offers a powerful platform to explore the complexities of female germline development while bypassing ethical and technical barriers in human and non-human primate research. This systematic review examined 23 articles that reported meiotic entry from differentiated pluripotent stem cells or ex vivo–cultured fetal germ cells from humans, cynomolgus monkeys or marmosets and were
-
Blastocysts derived from 0-pronuclear and 1-pronuclear zygotes represent an untapped pool of usable embryos Fertil. Steril. (IF 6.6) Pub Date : 2025-05-05
Arielle S. Yeshua M.D., Kerry Flannagan Ph.D., Joseph Lee B.A., Benjamin S. Harris M.D. M.P.H., Teresa Cacchione M.S. C.G.C., Kate Devine M.D., Eugene Toh B.S. M.Sc., Amy Jordan M.S., Cengiz Cinnioglu Ph.D., Phillip Romanski M.D. M.Sc. -
Natural vs. modified natural frozen-thawed embryo transfer cycles Fertil. Steril. (IF 6.6) Pub Date : 2025-05-04
Raoul Orvieto M.D. M.M.Sc. -
Fertilization and embryo development in fresh vs. vitrified oocytes with sperm from men with nonobstructive azoospermia Fertil. Steril. (IF 6.6) Pub Date : 2025-05-02
Christopher P. Moutos M.D., Anjile An M.P.H., Zev Rosenwaks M.D., Rony T. Elias M.D., Peter N. Schlegel M.D.To examine early embryo development of fresh vs. vitrified oocytes fertilized with microdissection testicular sperm extraction (mTESE) sperm from men with nonobstructive azoospermia.
-
Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2 Fertil. Steril. (IF 6.6) Pub Date : 2025-05-02
William H. Catherino M.D. Ph.D., Ayman Al-Hendy M.D. Ph.D., Souhil Zaim M.D., Nadia Bouzegaou M.D., Roberta Venturella M.D. Ph.D., Elizabeth A. Stewart M.D., Rui Wu Ph.D., Silvia Vannuccini M.D., Julie S. Perry M.D., Viatcheslav G. Rakov M.D., Malcolm G. Munro M.D.To assess the effects of relugolix combination therapy in women with uterine fibroids (UFs) and concomitant ultrasound-diagnosed adenomyosis.
-
Chromosome defects and male factor infertility Fertil. Steril. (IF 6.6) Pub Date : 2025-04-30
Dolores J. Lamb Ph.D. H.C.L.D. (ABB) C.C. (NRCC)Although a routine semen analysis and an endocrine evaluation (usually of the gonadotropins and androgen levels) are the cornerstone of clinical diagnostic evaluation of the male seeking evaluation and treatment of the couple with infertility, in recent years, the American Urological Association/American Society for Reproductive Medicine Practice Guidelines for Male Infertility stressed the importance
-
Reply from the authors: adding to the evolving landscape of fertility preservation research Fertil. Steril. (IF 6.6) Pub Date : 2025-04-29
Abigail Mercier B.Sc., Joshua Johnson Ph.D., Amanda Nicole Kallen M.D. -
Critical considerations on the strategy of oocyte vitrification before microscopic testicular sperm extraction Fertil. Steril. (IF 6.6) Pub Date : 2025-04-29
Yinwei Chen M.D., Yi Liu M.D., Chang Liu M.D. -
Laparoscopic uterine isthmus anastomosis Fertil. Steril. (IF 6.6) Pub Date : 2025-04-28
Yili Chen M.D., Fan Yang M.D., Junxiu Liu M.D., Shuzhong Yao M.D.To demonstrate a laparoscopic surgical technique for reconstructing posttraumatic uterine isthmus separation in an adolescent patient, focusing on anatomical restoration and fertility preservation.
-
Increasing Endometrial Thickness up to 12mm Is Associated with Increased Odds of Live Birth Among Fresh and Frozen-Thawed Autologous Transfers with or without PGT. Fertil. Steril. (IF 6.6) Pub Date : 2025-04-28
Julian A Gingold,Haotian Wu,Harry Lieman,Manvinder Singh,Sangita JindalOBJECTIVE To evaluate the impact of endometrial thickness on live birth among autologous assisted reproduction cycles. DESIGN Retrospective cohort SUBJECTS: All women undergoing autologous cycles with transfers in 2016-2018 reported to the Society for Assisted Reproductive Technology. EXPOSURE Endometrial thickness on the day of ovulation trigger in fresh cycles and closest to embryo transfer in frozen-thawed
-
Reply of the author to "A Critical Appraisal of Obstetric Outcomes Post-Myomectomy: Addressing Methodological Gaps". Fertil. Steril. (IF 6.6) Pub Date : 2025-04-27
Perrine Ginod,Ahmad Badeghiesh,Haitham Baglaf,Michael H Dahan -
Special considerations in assisted reproductive technology for patients with hematologic disease Fertil. Steril. (IF 6.6) Pub Date : 2025-04-25
Joshua Ewy M.D., Suneeta Senapati M.D. M.S.C.E., Nadia D. Ali M.D., Clarisa R. Gracia M.D. M.S.C.E.Populations with hematologic disorders seeking fertility care often present with a complex clinical picture, including disease-specific sequelae and comorbid conditions. Limited literature exists to help guide fertility clinics on the management of these patients, many of whom require multidisciplinary care coordination centered on patient-specific fertility goals. Thanks to advancements in life-prolonging
-
Corrigendum to "Risk analysis of torsion and malignancy for adnexal masses during pregnancy" (Fertil Steril 2009;91:1895-902). Fertil. Steril. (IF 6.6) Pub Date : 2025-04-25
Chih-Feng Yen,Shu-Ling Lin,William Murk,Chin-Jung Wang,Chyi-Long Lee,Yung-Kuei Soong,Aydin Arici -
Online fertility workup with video consultation for infertility patients; a randomized controlled trial Fertil. Steril. (IF 6.6) Pub Date : 2025-04-24
Hilde Grens M.D., Aleida G. Huppelschoten M.D. Ph.D., Jan A.M. Kremer M.D. Ph.D., Jan-Peter de Bruin M.D. Ph.D.To study whether an online fertility workup with video consultation is noninferior to a regular consultation with face-to-face contact in terms of patient-centeredness and shared decision-making.
-
Corrigendum to "Addition of Operative Hysteroscopy to Vacuum Aspiration for the Management of Early Pregnancy Loss After In Vitro Fertilization": [Fertil Steril 2024;122:1134-43.]. Fertil. Steril. (IF 6.6) Pub Date : 2025-04-24
Kai-Lun Hu,Jie Zhao,Mingmei Lin,Xiaoye Wang,Linjing Qi,Huan Liu,Dan Mo,Zhonghong Zeng,Ben W Mol,Rong Li -
Cumulative pretrigger progesterone levels are not superior to single-day levels for predicting a failed cycle in fresh embryo transfer cycles Fertil. Steril. (IF 6.6) Pub Date : 2025-04-23
Meghan Yamasaki D.O., Kerry Flannagan Ph.D., David Boedeker D.O., Shelley Dolitsky M.D., Nicole Banks M.D., Alan Decherney M.D., Eduardo Hariton M.D. M.B.A., Benjamin S. Harris M.D. M.P.H., Anthony Imudia M.D., Caleb Kallen M.D. Ph.D., Jessica Kanter M.D., Michael Levy M.D., Phillip Romanski M.D., Meike Uhler M.D., Kate Devine M.D., Micah Hill D.O. -
The number of autologous, vitrified mature oocytes needed to obtain three euploid blastocysts increases with age Fertil. Steril. (IF 6.6) Pub Date : 2025-04-23
Amalia Namath M.D., Kerry Flannagan Ph.D., Paul Pirtea M.D., James P. Toner M.D. Ph.D., Kate Devine M.D.To determine the number of mature oocytes required to make at least three euploid blastocysts.
-
Shifting the focus for fertility and reproductive health to medical students: a survey study building on lessons from surgical trainees Fertil. Steril. (IF 6.6) Pub Date : 2025-04-23
Sylvie Bowden M.D., Maitri Panchal B.Sc., Angela Pochakom B.Sc., Selphee Tang B.Sc., Amy Metcalfe Ph.D., Shu Foong M.D. F.R.C.S. -
Do young patients with male factor benefit from preimplantation genetic testing for aneuploidy? Insights from a secondary analysis Fertil. Steril. (IF 6.6) Pub Date : 2025-04-23
Sanjana Kulkarni M.D., Molly Kornfield M.D. -
Persistence of hypertension after pregnancy-related hypertensive disorders in women with polycystic ovary syndrome Fertil. Steril. (IF 6.6) Pub Date : 2025-04-23
Stefano Palomba M.D., Flavia Costanzi M.D. Ph.D., Rossella Cannarella M.D. Ph.D., Raffaella Votino M.D., Aldo E. Calogero M.D., Fabrizio Signore M.D., Donatella Caserta M.D.To assess whether polycystic ovary syndrome (PCOS) increases the risk of persistent hypertension in women with a history of pregnancy-related hypertensive disorder (PHD).
-
Reply to exploration of relevant factors related to the relationship between polycystic ovary syndrome and sexual response Fertil. Steril. (IF 6.6) Pub Date : 2025-04-22
Hester Pastoor M.Sc., Joop Laven M.D. Ph.D., Stephanie Both Ph.D. -
Hysteroscopic visualization and resection of embryo in biochemical pregnancy loss Fertil. Steril. (IF 6.6) Pub Date : 2025-04-22
Xiaoyan Guo M.D., Ziyu Zhou Ph.D., Chichi Xie M.D., Honghong Zhang M.D., Yiqi Yu M.D., Weihai Xu M.S., Jing Shu M.D., Yanpeng Wang M.D.To demonstrate the feasibility and skills of hysteroscopic embryonic resection in biochemical pregnancy.
-
From milestone to mainstream: the case for uterus transplantation Fertil. Steril. (IF 6.6) Pub Date : 2025-04-22
Elliott G. Richards M.D. Ph.D. -
Between Scylla and Charybdis: academic obstetrics and gynecology departments need to choose! Fertil. Steril. (IF 6.6) Pub Date : 2025-04-22
Steven Young M.D. Ph.D., Ruben Alvero M.D. -
Preimplantation genetic testing for aneuploidy and cumulative pregnancy rates: a closer look at the evidence Fertil. Steril. (IF 6.6) Pub Date : 2025-04-22
Ramazan Mercan M.D. -
-
Patients with a body mass index of ≥45 kg/m2 can safely undergo oocyte retrievals and anticipate similar assisted reproductive technology outcomes Fertil. Steril. (IF 6.6) Pub Date : 2025-04-20
Marissa Luck M.D., Elizabeth Rubin M.D., Bharti Garg M.B.B.S. M.P.H., Stephanie Powell B.S., Thomas O’Leary Ph.D., Paula Amato M.D., Diana Wu M.D., David Lee M.D., Lynn Bentley Davis M.D. M.S., Sacha Krieg M.D. Ph.D.To compare anesthesia and assisted reproductive technology (ART) outcomes in patients with a body mass index (BMI) of 40–44.9 kg/m2 with those with a BMI of ≥45 kg/m2 because these patients are often excluded from care.
-
Do you require any assistance?—assisted hatching may have negative impact on cycles using vitrified/warmed donor oocytes Fertil. Steril. (IF 6.6) Pub Date : 2025-04-20
Zachary Walker M.D. -
Intratesticular autologous platelet-rich plasma injection in couples with nonobstructive azoospermia: a narrative review Fertil. Steril. (IF 6.6) Pub Date : 2025-04-20
Yigit Cakiroglu M.D., Tansu Gudelci M.D., Bulent Tiras M.D.Azoospermia is the most severe form of male factor infertility presenting approximately 1% of the male population and 5%–10% of infertile men. Azoospermia is classified into two categories: obstructive azoospermia and nonobstructive azoospermia (NOA). Currently, microdissection testicular sperm extraction (mTESE) is still the primary approach especially for cases with NOA. However, there are still
-
“The birds, the bees, and the blastocysts” Fertil. Steril. (IF 6.6) Pub Date : 2025-04-18
Thomas A. Molinaro M.D. M.S.C.E., Maria Costantini-Ferrando M.D. Ph.D. -
Strengthening systematic review methods: reflections on Grading of Recommendations Assessment, Development and Evaluation, risk of bias, and clinical relevance Fertil. Steril. (IF 6.6) Pub Date : 2025-04-18
Alessandro Conforti M.D. Ph.D., Sandro C. Esteves M.D. Ph.D., Carlo Alviggi M.D. Ph.D.